CMS releases HCPCS codes for new COVID-19 antibody drug.
| Publicado en: | Billing Alert for Long-Term Care Vol. 22; no. 12; pp. 4 - 9 |
|---|---|
| Formato: | Journal Article |
| Publicado: |
HCPro
Dec2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=147702181&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 147702181 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15270246 500H jtl: Billing Alert for Long-Term Care issn: 15270246 maglogo: N pubinfo: dt: Dec2020 vid: 22 iid: 12 pid: 4175 pub: HCPro place: Danvers, Massachusetts artinfo: ui: 147702181 147702181 ppf: 4 ppct: 5 formats: fmt: @attributes: type: P tig: atl: CMS releases HCPCS codes for new COVID-19 antibody drug. aug: sug: subj: United States Centers for Medicare and Medicaid Services Health and Care Professions Council Coding COVID-19 Drug Therapy Antibodies, Monoclonal Insurance, Health, Reimbursement Medicare pubtype: Periodical doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|